← All Castle Biosciences INC filings

Castle Biosciences INC Form 4 insider transactions

NASDAQ
CSTL
Castle Biosciences INC
Form 4: Castle Biosciences CFO Acquires Restricted Stock Units
Frank Stokes, CFO of Castle Biosciences, acquired 48,744 Restricted Stock Units (RSUs) on March 4, 2024, according to a recent SEC filing.
NASDAQ
CSTL
Castle Biosciences INC
Form 4: Castle Biosciences CEO Derek Maetzold Reports Stock Transactions
Castle Biosciences CEO Derek Maetzold reports the acquisition and disposal of company stock, including the vesting of restricted stock units and the exercise of stock options.
NASDAQ
CSTL
Castle Biosciences INC
Form 4: Castle Biosciences Director Daniel Bradbury Sells Shares Under 10b5-1 Plan
Director Daniel Bradbury executed sales of Castle Biosciences (CSTL) common stock on March 4, 2024, under a pre-arranged 10b5-1 trading plan.